`
Radiation therapy, also known as radiotherapy, is a treatment approach that disrupts cancer cell growth by delivering powerful ionizing radiation directly to the site of cancer. The global radiation therapy market is on a strong growth trajectory, propelled by the rising worldwide prevalence of cancer and an increasing preference for non-invasive treatment alternatives. The report covers the study period 2021–2034, with 2025 as the base year.
Key Market Drivers
Rising Cancer Burden The growing incidence of cancer globally remains the foremost driver of market growth. According to the National Cancer Institute (NCI), approximately 1.73 million new cancer cases were diagnosed in the United States in 2018 alone. This expanding patient pool creates sustained demand for effective and accessible treatment options, with radiation therapy increasingly positioned as a frontline modality.
Technological Advancements Continuous innovation in radiotherapy technology is a key catalyst. New product launches by major industry players — supported by cutting-edge precision imaging, dosimetry software, and AI-assisted targeting — are accelerating adoption. A notable milestone was in March 2019, when DOSIsoft SA received FDA approval for its PLANET Onco Dose software, a personalized 3D dosimetry solution for 90Yttrium-based Selective Internal Radiation Therapy (SIRT). Similarly, VIEWRAY TECHNOLOGIES received FDA clearance in February 2019 for new soft tissue visualization capabilities integrated into its MRIdian MRI-Guided Radiation Therapy System.
Growing Adoption and Awareness Increasing awareness among patients and healthcare providers about the clinical benefits of radiation therapy — particularly its ability to precisely target tumors while minimizing damage to surrounding healthy tissue — is fueling broader adoption across diverse cancer types.
More Details: https://www.fortunebusinessinsights.com/industry-reports/radiation-therapy-market-101038
Market Restraints
Despite a promising outlook, the market faces notable challenges. Radiation therapy carries potential side effects that can impact patient quality of life, which may limit its adoption in certain clinical scenarios. Additionally, the high cost of advanced radiotherapy equipment and treatment procedures makes access difficult for populations in low- and middle-income countries, thereby restricting market penetration in emerging economies.
Market Segmentation
By Type The market is segmented into External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (brachytherapy), and others. EBRT holds the largest market share, encompassing sub-types such as 3D Conformal Radiation Therapy (3D-CRT), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Stereotactic Radiation Therapy, Photon Beam Radiation Therapy, and Intraoperative Radiation Therapy. EBRT's dominance is attributed to its lower radiation emission profile, which reduces the risk of side effects, and its high targeting accuracy at the precise site of cancer.
By End User The market is classified into Hospitals & Diagnostic Laboratories, Cancer Treatment & Research Centers, Academic Research Organizations, and others. Hospitals and cancer treatment centers represent the primary end-user segments, given their infrastructure for multidisciplinary cancer care.
Regional Analysis
North America leads the global radiation therapy market, driven by the high prevalence of cancer, well-established healthcare infrastructure, and widespread adoption of advanced radiotherapy systems across hospitals and cancer centers.
Europe is another significant market, supported by substantial government investments in oncology research and active collaborations between industry players to develop cost-effective radiotherapy solutions.
Asia Pacific is expected to register the highest growth rate during the forecast period, propelled by a large and growing patient population, increasing healthcare expenditure, and rapid economic development across countries like China and India.
Middle East & Africa is also witnessing rising demand, primarily driven by the growing need for affordable cancer treatment solutions in the region.
Key Players
The competitive landscape features several global and regional companies, including:
- Varian Medical Systems, Inc.
- Elekta AB
- Accuray Incorporated
- IBA
- ViewRay Technologies, Inc.
- Isoray Inc.
- Panacea Medical Technologies Pvt. Ltd.
- Provision Healthcare
- Mevion Medical Systems
- DOSIsoft SA
Conclusion
The global radiation therapy market is set for robust expansion through 2034, underpinned by the escalating global cancer burden, rapid technological innovation, and broadening clinical adoption. While cost barriers and treatment side effects remain challenges, ongoing product development and regulatory support are expected to open new growth avenues — particularly in high-growth regions like Asia Pacific.
`
Top comments (0)